CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis

Published:2023-11 Issue:39 Volume:29 Page:3166-3169
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Panichella Giorgia¹²,Aimo Alberto¹³

Affiliation:

1. Interdisciplinary Center for Health Sciences, Scuola Superiore Sant’Anna, Pisa, Italy

2. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

3. Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference22 articles.

1. Maurer M.S.; Hanna M.; Grogan M.; Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey). J Am Coll Cardiol 2016,68(2),161-172

2. Obi C.A.; Mostertz W.C.; Griffin J.M.; Judge D.P.; ATTR epidemiology, genetics, and prognostic factors. Methodist DeBakey Cardiovasc J 2022,18(2),17-26

3. Sanguinetti C.; Minniti M.; Susini V.; The journey of human transthyretin: Synthesis, structure stability, and catabolism. Biomedicines 2022,10(8),1906

4. Ruberg F.L.; Grogan M.; Hanna M.; Kelly J.W.; Maurer M.S.; Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019,73(22),2872-2891

5. Liepnieks J.J.; Zhang L.Q.; Benson M.D.; Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010,75(4),324-327

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP